Canadian Journal of Infectious Diseases and Medical Microbiology

Canadian Journal of Infectious Diseases and Medical Microbiology / 1996 / Article

Case Report | Open Access

Volume 7 |Article ID 237967 | https://doi.org/10.1155/1996/237967

Mark Pimentel, Lindsay E Nicolle, Salman Qureshi, "Candida albicans Epididymo-Orchitis and Fungemia in a Patient with Chronic Myelogenous Leukemia", Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 7, Article ID 237967, 3 pages, 1996. https://doi.org/10.1155/1996/237967

Candida albicans Epididymo-Orchitis and Fungemia in a Patient with Chronic Myelogenous Leukemia

Abstract

The fourth reported case of candidal epididymo-orchitis in the literature and the first reported case successfully cured with only low dose amphotericin B is described. A 75-year-old male with chronic myelogenous leukemia presented with acute testicular and epididymal swelling and pain. Subsequent investigations suggested the diagnosis of epididymo-orchitis due to Candida albicans. This was successfully treated with intravenous amphotericin B (total dose of 500 mg). Based on the three previous case reports and the current case several characteristic features that increased the suspicion of this entity were identified. These features include an immunocompromised state, candiduria, specific epididymal ultrasonographic appearance, as well as typical clinical features of epididymo-orchitis.

Copyright © 1996 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views47
Downloads200
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.